Camp 4 Therapeutics Corp (CAMP)

Dec 10, 2024

CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors - citybiz

Dec 10, 2024

Dec 10, 2024

CAMP4 Therapeutics Taps Former Alnylam CEO, RNA Pioneer to Drive Next-Gen Gene Therapy Platform - StockTitan

Dec 10, 2024

Dec 06, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

Dec 06, 2024

Dec 02, 2024

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Dec 02, 2024

Dec 02, 2024

CAMP4 Therapeutics to Present at Piper Sandler Healthcare Conference in NYC | CAMP Stock News - StockTitan

Dec 02, 2024

Nov 22, 2024

CAMP4 Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 22, 2024

Nov 21, 2024

CAMP4 Therapeutics Corporation (CAMP) reports earnings - Quartz

Nov 21, 2024

Nov 21, 2024

Camp4 Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 21, 2024

Nov 21, 2024

CAMP4 Therapeutics Secures $370M BioMarin Deal, Raises $82M in IPO Milestone | CAMP Stock News - StockTitan

Nov 21, 2024

Nov 20, 2024

CalAmp Files Bankruptcy to Complete Debt Restructuring - MSN

Nov 20, 2024

Nov 20, 2024

Camp4 gains after earning bullish views on Street - MSN

Nov 20, 2024

Nov 12, 2024

Biopharma IPOs raise nearly $1B in October from 5 public debuts - BioWorld Online

Nov 12, 2024

Nov 08, 2024

William Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform Recommendation - MSN

Nov 08, 2024

Nov 08, 2024

October IPOs in Biotech, Cleantech, Transportation, Retail and Homebuilder Sectors - Investorideas.com newswire

Nov 08, 2024

Nov 06, 2024

Camp4 Therapeutics initiated with an Overweight at Piper Sandler - MSN

Nov 06, 2024

Nov 06, 2024

JP Morgan Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation - MSN

Nov 06, 2024

Nov 06, 2024

JPMorgan sees "breakthrough potential" in CAMP4 stock, bets big on RNA tech - Investing.com Australia

Nov 06, 2024

Nov 05, 2024

CAMP4 Analyst Highlights Rare Disease Platform Potential - Benzinga

Nov 05, 2024

Nov 05, 2024

Camp4 stock gains after earning bullish views (CAMP:NASDAQ) - Seeking Alpha

Nov 05, 2024

Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating - Investing.com

Nov 05, 2024

Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating By Investing.com - Investing.com Canada

Nov 05, 2024

Nov 05, 2024

Leerink sets stock target for CAMP4, cites broad UCD treatment potential - Investing.com India

Nov 05, 2024

Nov 05, 2024

Piper Sandler optimistic on CAMP4 stock, cites potential in pioneering RNA technology - Investing.com

Nov 05, 2024

Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline

Oct 25, 2024

Oct 25, 2024

Internet of Things (IoT) in Construction Market Worth Over $61.7 Billion by 2030Industry Analysis and Forecast with Profiles of 37 Major Companies Including Autodesk, Calamp Corp, Caterpillar, Dronedeploy - GlobeNewswire

Oct 25, 2024

Oct 25, 2024

CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN

Oct 25, 2024

Oct 20, 2024

Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.

Oct 20, 2024

Oct 18, 2024

Camp4 Therapeutics sees $8.4 million stock purchase by Northpond Ventures - Investing.com India

Oct 18, 2024

Oct 18, 2024

Camp4 Therapeutics sees $7.99m stock purchase by investors By Investing.com - Investing.com India

Oct 18, 2024

Oct 18, 2024

Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com India

Oct 18, 2024

Oct 18, 2024

CAMP4 Rings the Opening Bell - Nasdaq

Oct 18, 2024

Oct 16, 2024

Insider Trading Activity Tuesday: Top Buys and Sells in US Stocks Revealed - Investing.com

Oct 16, 2024

Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by Polaris - Investing.com

Oct 15, 2024

Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by 5AM Ventures - Investing.com Australia

Oct 15, 2024

Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock - Investing.com India

Oct 15, 2024

Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock By Investing.com - Investing.com Australia

Oct 15, 2024